Natixis Advisors’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-17,187
Closed -$438K 1518
2022
Q2
$438K Buy
+17,187
New +$438K ﹤0.01% 1310